Assessment of Clinical Significance of Molecular Streptococcus agalactiae Detection in Patients With Suspected Pneumonia - Takeaways - MDSpire

Assessment of Clinical Significance of Molecular Streptococcus agalactiae Detection in Patients With Suspected Pneumonia

  • By

  • Mona Mustafa Hellou

  • Guyu Li

  • Rita Igwilo-Alaneme

  • Abinash Virk

  • Elias Hellou

  • Zane Lancaster

  • Robin Patel

  • December 24, 2025

  • 0 min

Share

  • 1

    Streptococcus agalactiae (GBS) is detected in respiratory specimens, complicating its classification as a pathogen or colonizer in pneumonia cases.

  • 2

    In a study of 109 patients, GBS was classified as a pneumonia pathogen in 47.7% of cases and a nonpathogen in 52.3%.

  • 3

    ID consultations were performed in 33.0% of cases, with GBS considered a pathogen in 30.6% of those consultations.

  • 4

    Common comorbidities among patients included pulmonary, gastrointestinal, neurologic, and cardiovascular diseases, as well as obesity.

  • 5

    Only 10.2% of GBS-positive specimens from the BF-PP were culture positive for GBS, indicating uncertainty in its clinical significance.

Original Source(s)

Assessment of Clinical Significance of Molecular Streptococcus agalactiae Detection in Patients With Suspected Pneumonia

  • by Mona Mustafa Hellou, Guyu Li, Rita Igwilo-Alaneme, Abinash Virk, Elias Hellou, Zane Lancaster, Robin Patel

  • December 24, 2025

Related Content

Hospital-Treated Infections Linked to Dementia Risk

Investigators identify 29 conditions associated with dementia risk in nationwide registry analysis.

Pneumonia Patterns Postpandemic

Pneumococcal and RSV RAD-CAP incidence increased as SARS-CoV-2 incidence declined, disproportionately affecting older adults.

Age and hypoalbuminemia independently predict pulmonary consolidation in children with 23S rRNA A2063G-mutant Mycoplasma pneumoniae pneumonia: a retrospective single-center study